Judge to Allow Punitives in Levaquin MDL
Startling new evidence has emerged in the Schedin v. Johnson & Johnson, et al. trial, a multidistrict litigation involving the pharmaceutical drug Levaquin, which has been linked to painful and […]
Baxter Found Liable in First Contaminated Herapin Trial
Recently, a Cook County jury awarded $625,000 to the estate of a 63 year old Chicago area man, Steven Johansen, who was administered Baxter blood thinner that contained a contaminated […]
Drug Advertisement Claims: Fact or Fiction?
According to an alarming new study published in the Archives of Otolaryngology, a majority of the advertisements appearing in leading medical journals aimed at ear, nose and throat specialists are […]
Transparency in Drug Information
Pharmaceutical companies are notorious for only disclosing the information they feel will help sell products. With the help of judges and labeling such as trade secrets, these companies are often […]
Off-Label Marketing Continues Despite Enforcement Efforts
With the proliferation of prescription drug use in America, pharmaceutical companies are constantly trying to find new uses for medicines already in the marketplace. To gain acceptance for such uses, […]
DePuy Pinnacle Hip Implant: Litigation to be Consolidated
Recently, a panel of federal judges decided to consolidate all DePuy Pinnacle hip implant lawsuits to a multi-district litigation and transferred it to the federal court in Texas. Pinnacle is […]
Yaz, Yazmin, Beyaz and Ocella Increases Risk of Blood Clots Three-fold, Say New Studies
The FDA announced Tuesday that it is in the process of reviewing and finalizing the results of a study on the health risks associated with drospirenone, a main active ingredient […]
Pre-Market Tests Only Telling Part of the Story
Before pacemakers, stents and other medical devices for the heart are approved for use by the U.S. Food and Drug Administration, the devises must be put through pre-market testing. A study by […]
GAO Report Criticizes FDA on 510k Process
The Government Accountability Office (GAO) recently released its evaluation on how the FDA has responded to the GAO’s 2009 findings on the shortcomings of the FDA’s premarket review process for medical devices. […]
Settlement Disaster Relief Funds
A recent trend in the settlement of claims arising out of disasters has been to set up a fund directly from a responsible party, seeking to make direct payments. This […]